Keiki Sakurama
Aso, 8692225, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction to: Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report.
Journal: Journal of pharmaceutical health care and sciences
Published: May 05, 2023
Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case control study.
Journal: Journal of pharmaceutical health care and sciences
Published: December 30, 2022
The Binding of Aripiprazole to Plasma Proteins in Chronic Renal Failure Patients.
Journal: Toxins
Published: October 14, 2021
An in-vitro comparative study of the binding of caspofungin and micafungin to plasma proteins.
Journal: The Journal of pharmacy and pharmacology
Published: June 21, 2021
Effects of Uremic Toxins on the Binding of Aripiprazole to Human Serum Albumin.
Journal: Biological & pharmaceutical bulletin
Published: March 01, 2021
Interaction of Benzbromarone with Subdomains IIIA and IB/IIA on Human Serum Albumin as the Primary and Secondary Binding Regions.
Journal: Molecular pharmaceutics
Published: January 22, 2021
Effects of Oxidation of Human Serum Albumin on the Binding of Aripiprazole.
Journal: Biological & pharmaceutical bulletin
Published: June 02, 2020
Characterization of the Interaction of Daptomycin With Site II on Human Serum Albumin.
Journal: Journal of pharmaceutical sciences
Published: March 23, 2020
Interaction of Aripiprazole With Human α1-Acid Glycoprotein.
Journal: Journal of pharmaceutical sciences
Published: June 27, 2019
Further Evidence Regarding the Important Role of Chlorine Atoms of Aripiprazole on Binding to the Site II Area of Human Albumin.
Journal: Journal of pharmaceutical sciences
Published: November 03, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026